Patent details
300556
Product Name:
Combinatie van fluticason en formeterol, of farmaceutisch aanvaardbare zouten of derivaten ervan als beschermd door het basisoctrooi, in het bijzonder fluticasonproprionaat en formetrerolfumaraat.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300556
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1102579
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300556
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
1
Marketing Authorization Number:
ML21395...397
Marketing Authorization Type:
EEA
Marketing Authorization Date:
10/07/2012
Marketing Authorization Country:
Cyprus (CY)
2
Marketing Authorization Number:
RVG 107249
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/07/2012
Marketing Authorization Country:
Netherlands (NL)
3
Marketing Authorization Number:
RVG 107248
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/07/2012
Marketing Authorization Country:
Netherlands (NL)
4
Marketing Authorization Number:
RVG 107247
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/07/2012
Marketing Authorization Country:
Netherlands (NL)
5
Marketing Authorization Number:
RVG 107243
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/07/2012
Marketing Authorization Country:
Netherlands (NL)
6
Marketing Authorization Number:
RVG 107242
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/07/2012
Marketing Authorization Country:
Netherlands (NL)
7
Marketing Authorization Number:
RVG 107222
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
12/07/2012
Marketing Authorization Country:
Netherlands (NL)
Dates
Filing date:
29/11/2012
First Marketing Authorization date:
10/07/2012
Grant date:
20/08/2013
Activation date:
02/08/2019
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
29/11/2012
SPC/SPC Extension Expiration Date:
01/08/2024
Lapsed By Expiration Date:
02/08/2024
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
29/11/2012
Name:
JAGOTEC AG
Address:
Eptingerstrasse 5, 4132, Muttenz, Switzerland (CH)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
29/11/2012
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
32/24
Publication date:
07/08/2024
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
32/19
Publication date:
07/08/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
2013/35
Publication date:
28/08/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
2012/50
Publication date:
12/12/2012
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
15/08/2023
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
CPA Global (Patrafee)
Filing date
Document type
Document Description
Number of pages
File Type
20/08/2013
Outgoing Correspondence
Outgoing Letter
1
PDF
/6/5/5/0/0/0400300556/docs/300556_1_outgoingcorrespondence20130820.pdf
20/08/2013
SPC Documents
Certificate SPC
1
PDF
/6/5/5/0/0/0400300556/docs/300556_8_supplprotectioncertificate20210301031827357.pdf
01/05/2013
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/6/5/5/0/0/0400300556/docs/300556_0_incomingcorrespondencepaper20210301031706284.pdf
07/02/2013
Outgoing Correspondence
Outgoing Letter
2
PDF
/6/5/5/0/0/0400300556/docs/300556_3_outgoingcorrespondence20130207.pdf
30/11/2012
Outgoing Correspondence
Outgoing Letter
1
PDF
/6/5/5/0/0/0400300556/docs/300556_13_outgoingcorrespondence20121130.pdf
29/11/2012
Application Form
First filed application form
2
PDF
/6/5/5/0/0/0400300556/docs/300556_2_applicationform20121129.pdf
29/11/2012
SPC Documents
Annex SPC
27
PDF
/6/5/5/0/0/0400300556/docs/300556_4_supplprotectioncertificate20210301031151745.pdf
29/11/2012
SPC Documents
Marketing Authorization SPC
27
PDF
/6/5/5/0/0/0400300556/docs/300556_5_supplprotectioncertificate20210301024826957.pdf
29/11/2012
SPC Documents
Annex SPC
10
PDF
/6/5/5/0/0/0400300556/docs/300556_6_supplprotectioncertificate20210301030028204.pdf
29/11/2012
SPC Documents
Annex SPC
27
PDF
/6/5/5/0/0/0400300556/docs/300556_7_supplprotectioncertificate20210301025542500.pdf
29/11/2012
SPC Documents
Annex SPC
10
PDF
/6/5/5/0/0/0400300556/docs/300556_9_supplprotectioncertificate20210301022954453.pdf
29/11/2012
SPC Documents
Summary of the characteristics of the product
18
PDF
/6/5/5/0/0/0400300556/docs/300556_10_supplprotectioncertificate20210301023330813.pdf
29/11/2012
SPC Documents
Annex SPC
10
PDF
/6/5/5/0/0/0400300556/docs/300556_11_supplprotectioncertificate20210301025807230.pdf
29/11/2012
SPC Documents
SPC Documents
6
PDF
/6/5/5/0/0/0400300556/docs/300556_12_supplprotectioncertificate20210301024555050.pdf